The Early Detection Research Network: Biomarker Reference Laboratories
This RFA is a reissue of RFA CA-99-008, which was published in the NIH Guide on March 16, 1999.
NCI's Division of Cancer Prevention invites new and competing renewal cooperative agreement applications to continue the Early Detection Research Network's national Biomarker Reference Laboratories, which have the responsibility for the development, evaluation, and validation of biomarkers for earlier cancer detection and risk assessment. The network has four main components: Biomarker Developmental Laboratories, Biomarker Reference Laboratories, Clinical Epidemiology and Validation Centers, and a Data Management and Coordinating Center.
This RFA will use the NIH Cooperative Agreement (U24) award mechanism.
For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2000.